Salix Pharmaceuticals, Ltd. (NASDAQ:SLXP) announced financial and operating results for the third quarter ended September 30, 2009.
Total product revenue was $65.7 million for the third quarter of 2009, a 53 percent increase compared to $42.9 million for the third quarter of 2008. Total product revenue for the first nine months of 2009 was $162.7 million [...]

Continue reading " Salix Pharmaceuticals Reports 3Q2009 Results "